BioCryst Pharmaceuticals Inc Logo

BioCryst Pharmaceuticals Inc (BCRX): Eigentümerstruktur

Takani Score ?
64.5

Preis (12.10.2026)52W Hoch52W Tief
8,36 US Dollar11,22 US Dollar6 US Dollar
Analysten KonsensBuy Outperform Hold Underperform Sell
20,727 US Dollar7 2 2 0 0
Externe Analystenschätzungen (Quelle: EODHD). Keine Anlageberatung, keine Anlageempfehlung von Takani.
#SharesShort [%] Short Ratio
255.535.10510,84 5,15

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name BioCryst Pharmaceuticals Inc
Mitarbeiter 435
Handelsplatz NASDAQ
Ticker Symbol BCRX
IPO Datum 1994-03-03
Adresse 4505 Emperor Boulevard, Durham, NC, United States, 27703

Unternehmensführung

RangNamePosition
1Mr. Charles K. GayerCEO, President & Director
2Mr. Babar GhiasCFO & Head of Corporate Development
3Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary
4Mr. John RueschChief Technical Operations Officer
5Dr. David W. Jenkins M.A., Ph.D.Chief Scientific Officer
6Nick WilderManager of Investor Relations
7Ms. Stephanie AngeliniChief People Officer & Communications Officer
8Dr. William P. Sheridan MBBSChief Development Officer
9Dr. Yarlagadda S. Babu Ph.D.Chief Discovery Officer
10Ms. Jinky Ang RosselliChief Data Innovation Officer

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1BlackRock Inc9,35%0,20 Mrd. USD
2RA Capital Management, LLC6,19%0,14 Mrd. USD
3State Street Corp5,94%0,13 Mrd. USD
4Deerfield Management Co5,91%0,13 Mrd. USD
5Vanguard Capital Management, LLC4,45%0,10 Mrd. USD
6Vanguard Portfolio Management, LLC4,36%0,10 Mrd. USD
7TCG Crossover Management, LLC4,31%0,09 Mrd. USD
8Perceptive Advisors LLC4,03%0,09 Mrd. USD
9Jupiter Topco LLC3,73%0,08 Mrd. USD
10HHG PLC3,49%0,08 Mrd. USD
11Vestal Point Capital LP3,25%0,07 Mrd. USD
12Two Sigma Investments LLC2,65%0,06 Mrd. USD
13Geode Capital Management, LLC2,45%0,05 Mrd. USD
14Aberdeen Group PLC2,08%0,05 Mrd. USD
15UBS Group AG1,99%0,04 Mrd. USD
16Bank of America Corp1,88%0,04 Mrd. USD
17The Goldman Sachs Group Inc1,75%0,04 Mrd. USD
18Frazier Life Sciences Management, L.P.1,57%0,03 Mrd. USD
19Nuveen, LLC1,57%0,03 Mrd. USD
20Nantahala Capital Management, LLC1,49%0,03 Mrd. USD